GW&K Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43K | Sell |
81
-10
| -11% | -$5.31K | ﹤0.01% | 539 |
|
|
2025
Q1 | $58K | Buy |
91
+4
| +5% | +$2.55K | ﹤0.01% | 469 |
|
|
2024
Q4 | $62K | Hold |
87
| – | – | ﹤0.01% | 446 |
|
|
2024
Q3 | $91K | Buy |
87
+8
| +10% | +$8.37K | ﹤0.01% | 403 |
|
|
2024
Q2 | $83K | Buy |
79
+6
| +8% | +$6.3K | ﹤0.01% | 399 |
|
|
2024
Q1 | $70K | Buy |
73
+14
| +24% | +$13.4K | ﹤0.01% | 396 |
|
|
2023
Q4 | $52K | Buy |
59
+1
| +2% | +$881 | ﹤0.01% | 401 |
|
|
2023
Q3 | $48K | Buy |
58
+25
| +76% | +$20.7K | ﹤0.01% | 396 |
|
|
2023
Q2 | $24K | Buy |
+33
| New | +$24K | ﹤0.01% | 455 |
|
|
2022
Q3 | – | Sell |
-19
| Closed | -$11K | – | 738 |
|
|
2022
Q2 | $11K | Buy |
19
+10
| +111% | +$5.79K | ﹤0.01% | 467 |
|
|
2022
Q1 | $6K | Buy |
+9
| New | +$6K | ﹤0.01% | 522 |
|